MSDC-0160

· Metabolic Solutions Development Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MSDC-0160, covering 2013-05-03 to 2014-11-05. Get the full timeline:

Most recent: Clinical Trial Update: 3-month Study of MSDC-0160 Effects on Brain Glucose Utilization, Cognition & Safety in Subjects With Alzheimer's Disease [Phase 2]

See pricing